NextPlat (NXPL) Cash & Equivalents Growth (3y) (2017 - 2026)
Powered by 
Analysis
NextPlat (NXPL) Cash & Equivalents Growth (3y) (2017 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn | 11.05% |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn | 12.11% |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn | 10.39% |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn | 5.31% |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn | 46.62% |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn | 30.60% |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn | - |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn | 14.59% |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn | 40.23% |
| 10 | NextPlat | 24.77 Mn | 12.93 Mn | 4.69 Mn | -16.63% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -16.63% |
| Mar 31, 2026 | -13.01% |
| Dec 31, 2025 | -10.14% |
| Sep 30, 2025 | 3.75% |
| Jun 30, 2025 | -6.68% |
| Mar 31, 2025 | -6.80% |
| Dec 31, 2024 | 4.95% |
| Sep 30, 2024 | 5.91% |
| Jun 30, 2024 | 19.95% |
| Mar 31, 2024 | 247.78% |
| Dec 31, 2023 | 230.49% |
| Sep 30, 2023 | 218.29% |
| Jun 30, 2023 | 302.28% |
| Mar 31, 2023 | 394.73% |
| Dec 31, 2022 | 530.52% |
| Sep 30, 2022 | 415.11% |
| Jun 30, 2022 | 295.66% |
| Mar 31, 2022 | 484.36% |
| Dec 31, 2021 | 394.40% |
| Sep 30, 2021 | 338.37% |